HeartBeam Announces Automated Cardiac Detection Patent Granted For HeartBeam AIMIGo System
Portfolio Pulse from Happy Mohamed
HeartBeam, Inc. (NASDAQ:BEAT) has received a notice of allowance from the US Patent and Trademark Office for a key patent relating to the AI capability in its HeartBeam AIMIGo System. The patent is for a hand-held device for automatic cardiac risk and diagnostic assessment.
May 25, 2023 | 12:35 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HeartBeam, Inc. (NASDAQ:BEAT) has been granted a patent for the AI capability in its HeartBeam AIMIGo System, which could strengthen its IP position in the ambulatory VECG market.
The granted patent for HeartBeam's AI capability in its HeartBeam AIMIGo System could potentially strengthen the company's IP position in the ambulatory VECG market. This may lead to increased market share and revenue, positively impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100